Senseonics Holdings, Inc. (NYSE-MKT: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the second quarter ended June 30, 2017.
{iframe}http://www.businesswire.com/news/home/20170809006112/en/Senseonics-Holdings-Reports-Quarter-2017-Financial-Results{/iframe}